NanoViricides
NNVC
NanoViricides (NNVC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Noble Capital Markets | Initiated Coverage | Outperform | $6.00 | Jul 6, 2026 |
| EF Hutton | Maintained | Buy | $6.50 | May 7, 2024 |
| EF Hutton | Maintained | Buy | $6.50 | Feb 16, 2024 |
| EF Hutton | Maintained | Buy | $5.25 | Apr 18, 2023 |
| EF Hutton | Maintained | Buy | $5.25 from $8.50 | Feb 28, 2023 |
Frequently asked questions
What is the latest analyst rating on NNVC?
On Jul 6, 2026, Noble Capital Markets initiated coverage of NanoViricides at Outperform with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.